Search Blog
March 2014
« Feb   Apr »


Chrysalis Capital IX Corporation Completes Initial Public Offering


Chrysalis Capital IX Corporation Completes Initial Public Offering

Toronto, Ontario CANADA, March 28, 2014 /FSC/ – Chrysalis Capital IX Corporation (NYN.P – TSX Venture)

The Chrysalis Capital Group Inc. (“Chrysalis”) is pleased to announce the completion of the initial public offering (“IPO”) of its ninth capital pool company (“CPC”), Chrysalis Capital IX Corporation (the “Corporation”). The Corporation issued 6,141,000 common shares at a price of $0.10 per share for gross proceeds to the Corporation of $614,100.

When combined with the Corporation’s cash proceeds raised prior to the IPO ($235,000 in seed financing as more fully described in the Corporation’s prospectus dated March 5, 2014), the Corporation has raised total gross proceeds of $849,100 and has a total of 10,841,000 common shares issued and outstanding. The net proceeds will be used to identify and evaluate assets of businesses for acquisition with a view to completing a “Qualifying Transaction” under the CPC program of the TSX Venture Exchange (the “TSX-V”).

“The successful IPO of our ninth CPC represents a continuation of Chrysalis’ portfolio approach to the CPC Program,” commented Robert Munro, CEO of Chrysalis. “As the only full-time, professional company focused on CPCs, Chrysalis has developed unique expertise at working with, and investing in, companies looking to go public.”

It is anticipated that the common shares of the Corporation will commence trading on the TSX-V under the stock symbol “NYN.P” on Friday, March 28, 2014 upon confirmation by the TSX-V of closing.

PI Financial Corp. acted as agent in respect of the IPO and received an option to acquire an aggregate of 614,100 common shares for a period of two years from the date of listing at an exercise price of $0.10 per share. A corporate finance fee and a cash commission of 10% of the gross proceeds of the IPO were also paid.

In addition, the Corporation granted an aggregate of 975,690 stock options to its directors and officers at an exercise price of $0.10 per share for a period of ten years from the date of grant and 108,410 charitable options at an exercise price of $0.10 per share for a period of ten years from the date of grant to the Exclamation Foundation; continuing Chrysalis’ long-standing commitment to corporate giving.

Chrysalis is focused on generating superior shareholder returns through the creation of a series of unique CPCs. To date, Chrysalis has completed eight CPC Qualifying Transactions. For more information about Chrysalis, please visit

Neither TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at

For more information, please contact:

Robert Munro, Chief Executive Officer and Chief Financial Officer

Chrysalis Capital IX Corporation

T: (888) 448-4946

To view this press release as a PDF file, click onto the following link:

Maximum News Dissemination by FSCwire.